The Misleading Market?
The biotech stocks continue to begin their daily trading relying on opinionated articles implanted by bloggers on the Internet rather than on the firms’ voiced news.  It is unfortunate that we continue to observe many investors incapable of pinpointing the differences between the fake and the real in interpreting the news. We do not blame them; however, as those who are misleading use sophisticated-looking analysis. Although they do not make sense they still impress and mislead.

The time has come for investors to open their eyes and ears to avoid being fooled; missing lucrative investment opportunities . . .